4th Joint Transnational Call for Proposals (2021)

Basic Information

The JTC2021 is constructed around three research areas: Translating Basic to Clinical Research, Data and Information and Communication Technology and Research towards Responsible Implementation in Healthcare. Each proposal MUST address the modules Clinical Research, Towards Application in Healthcare and ELSA. Inclusion of modules Pre-clinical Research and Health Economic Research is optional. Each consortium submitting a proposal must involve at least three partners eligible for funding from three different countries whose funders participate in the call. At least two partners out of the minimum three eligible project partners of the consortium must be from two different EU Member States or Associated Countries. The project coordinator must be eligible to be funded by his participating funding organisation. The maximum number of partners per project at the pre-proposal stage is six

Network ERA PerMed
Website http://www.erapermed.eu/joint-calls/joint-transnational-call-2021/
Aim of the joint call “MULTIDISCIPLINARY RESEARCH PROJECTS ON PERSONALISED MEDICINE – DEVELOPMENT OF CLINICAL SUPPORT TOOLS FOR PERSONALISED MEDICINE IMPLEMENTATION” - ERA PerMed fosters research and innovation activities on clinical research, medical informatics, and research on ethical, legal, and social aspects in the field of PM. This implies multidisciplinary activities. The overarching goal is to improve disease prevention and disease management, based on more efficiently characterized and defined patient stratification, diagnostics, and tailored treatment/prevention protocols for individuals at risk of disease. Close interaction with the different key contributors along the value chain should be included right from the project development phase to bridge the gap between first discoveries or inventions to market access. Research proposals submitted are expected to demonstrate the applicability of project outcomes to clinical practice and to combine clinical research, ELSI with data technologies
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 14/12/2020
Deadline Pre-Proposal 04/03/2021 Submitted proposal: 217
Deadline Full-Proposal 17/06/2021 Submitted proposal: 59
Evaluation End Date 07/09/2021 Successful proposal: 0 Proposals funded: 22
Is call co-funded? No
Call follow up funding
  • There are mechanisms in place to monitor
Call reasons
  • Achieving critical mass
  • Sharing competences and associated work
  • Addressing global issues
  • Access to expertise from different countries
Research fields
  • Health
  • Other: ERA PerMed adheres to the definition stated in the Strategic Research and Innovation Agenda (SRIA) of PerMed, adopted from the Horizon2020 advisory group : “Personalised Medicine refers to a medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.”
Type of research
  • Basic research
  • Applied Research
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
  • Other: Patient organizations
Participating networks n/a

Organisations Participating

Country Organisation
Medical Research Administration Chief Scientist Office Israeli Ministriy of Health
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Brazil Brazilian National Council for the State Funding Agencies (CONFAP)
Chile National Research and Development Agency (ANID)
Croatia Ministry of Science, Education and Sports (MSES-MZOS)
Denmark Innovation Fund Denmark (Innofond)
Egypt Academy of Scientific Research and Technology (ASRT)
Estonia Estonian Science Foundation (ETAG)
Finland Academy of Finland (AKA)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Germany Federal Ministry of Health (BMG)
Germany German Aerospace Center (DLR)
Germany Saxon State Ministry for Sciences and the Arts (SMWK)
Hungary National Research, Development and Innovation Office (NKFIH)
Italy Lombardy Foundation for Biomedical Research (FRRB)
Italy Ministry of Health (MOH/MDS)
Italy Tuscany Region (TOS)
Latvia State Education Development Agency (VIAA)
Luxembourg National Fund for Research (FNR)
Norway Research Council of Norway (RCN)
Panama Secretariat of Science, Technology and Innovation (SENACYT)
Poland National Centre for Research and Development (NCBiR)
Romania Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Spain DEPARTMENT OF HEALTH - GOVERNMENT OF CATALONIA (DDS-GDC)
Spain Government of Navarra (CFN)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Sweden Swedish Research Council (VR/SRC)
Turkey The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
AGORA Algorithm of Graft Outcome in Renal Allotransplantation 01/05/2022 01/05/2025 4
ArtiPro Artificial intelligence for personalised medicine in depress... 01/05/2022 01/05/2025 7
BRAVA Behaviours in REM sleep: personalised Automatic 3D Video Ana... 01/04/2022 01/04/2025 5
CORSAI Raman analysis of saliva from COPD patients as new biomarker... 01/02/2022 01/02/2025 5
CytoMARK Development of a personalised non-invasive diagnosis of endo... 01/02/2022 01/02/2025 6
ECLAI Personalized Clinical Management of Endometrial Cancer using... 01/02/2022 01/02/2025 4
EDAP-AD Early and accurate diagnostic and prognostic markers for Alz... 01/09/2022 01/09/2025 6
IMAGene Epigenomic and machine learning models to predict pancreatic... 01/04/2022 01/04/2025 6
MIRACLE A Machine learning approach to Identify patients with Resect... 01/04/2022 01/04/2025 6
PER-NEPH Implementation of personalised management in nephrotic syndr... 01/04/2022 01/04/2025 4
PETictCAC Clinical decision support for predicting cachexia in cancer ... 4
PRE-CARE ML Predicting Cardiovascular Events Using Machine Learning 02/05/2022 02/05/2025 5
Pattern-Cog Personalized aging pattern for early risk detection and prev... 01/06/2022 01/06/2025 6
PerCard Personalised Prognostics and Diagnostics for Improved Decisi... 01/01/2022 01/01/2025 4
PerFluid Personalised perfusion guided fluid therapy 01/08/2022 01/08/2025 5
PerSAIDs PERsonalised medicine for SAIDs 01/05/2022 01/05/2025 6
REDESIGN TREatment DEcision baSed on organoIds in Gastric caNcer 4
SYMMETRY Subpopulation heterogeneitY and MicroenvironMental Engagemen... 7
ScandRA Personalised medicine in RA by combining genomics, biomarker... 15/04/2022 15/04/2025 6
TECH-TOYS Acquire digiTal biomarkErs in infanCy witH sensorized TOYS f... 01/09/2022 01/09/2025 6
WODIA Personalized Medicine Screening and Monitoring Programme for... 01/06/2022 01/06/2025 5
i-RECORDS International - Rapid rEcognition of CORticosteroiDs sensiti... 31/05/2022 31/05/2025 6